In vivo experiments have subsequently demonstrated that anti-MPO antibodies alone have the ability to induce full-blown vasculitis, whereas anti-PR3 antibodies have this potential only under specific conditions and typically induce milder forms of the disease [66,67,68,69,70]. Here, PRTN3 is linked to vasculitis.